Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/121142
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation |
Autor: | Martínez-Martínez, Irene; Ordóñez, Adriana; Navarro-Fernández, José; Pérez-Lara, Ángel; Gutiérrez-Gallego, Ricardo; Giraldo, R. CSIC ORCID; Martínez, Constantino; Llop, Esther; Vicente, Vicente; Corral, Javier | Palabras clave: | Antithrombin Glycosylation Heparin |
Fecha de publicación: | 2010 | Editor: | Ferrata Storti Foundation | Citación: | Haematologica 95(8):1358-1365 (2010) | Resumen: | Background Identification of mutations in the SERPINC1 gene has revealed different mechanisms responsible for antithrombin deficiency. Deletions and nonsense mutations associate with type I deficiency. Certain missense mutations cause type II deficiency by affecting the heparin binding site or the reactive center loop, while others result in type I deficiency by intracellular retention or RNA instability. Design and Methods We studied the molecular, biochemical, proteomic and glycomic characterization of a new natural mutant (K241E) that may be classified as pleiotropic. Results The mutation caused a significant decrease in the anticoagulant activity mainly due to a reduced heparin affinity and a modification of the electrostatic potential that might explain the impaired ability of the mutant protein to form complexes with the target protease in the absence of heparin. Mass spectrometry and glycomic analyses confirmed an increased molecular weight of 800 Da in the mutant protein possibly due to core-fucosylation, provoking the loss of heparin affinity. Additionally, carriers of this mutation also have a minor mutant isoform that still followed normal glycosylation, retaining similar heparin affinity to wild-type α−antithrombin, and certain anticoagulant activity, which may explain the milder thrombotic risk of patients carrying this mutation. Similar results were observed using recombinant K241E antithrombin molecules. Conclusions Our data suggest a new mechanism involved in antithrombin type II deficiency by indirectly affecting the glycosylation of a natural variant. Additional studies are required to confirm this hypothesis. | Descripción: | 8 p.-8 fig. | Versión del editor: | http://dx.doi.org/ 10.3324/haematol.2009.015487 | URI: | http://hdl.handle.net/10261/121142 | DOI: | 10.3324/haematol.2009.015487 | ISSN: | 0390-6078 | E-ISSN: | 1592-8721 |
Aparece en las colecciones: | (CIB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Haematologica_2010.pdf | Artículo principal | 453 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
14
checked on 19-mar-2024
SCOPUSTM
Citations
30
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
27
checked on 29-feb-2024
Page view(s)
406
checked on 17-abr-2024
Download(s)
251
checked on 17-abr-2024